Bicvic, Antonela; Scherrer, Natalie; Schweizer, Juliane; Fluri, Felix; Christ-Crain, Mirjam; De Marchis, Gian Marco; Luft, Andreas R; Katan, Mira (2022). A novel biomarker panel index improves risk stratification after ischemic stroke. European stroke journal, 7(2), pp. 158-165. Sage 10.1177/23969873221090798
Text
23969873221090798.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (227kB) |
Background
We investigated 92 blood biomarkers implicated in the pathophysiological pathways of ischemic injury, inflammation, hemostasis, and regulation of vascular resistance to predict post-stroke mortality.
Aim
Based on the most promising markers, we aimed to create a novel Biomarker Panel Index (BPI) for risk stratification.
Methods
In this prospective study, we measured 92 biomarkers in 320 stroke patients. The primary outcome measure was mortality within 90 days. We estimated the association of each biomarker using logistic regression adjusting for multiple testing. The most significant 16 biomarkers were used to create the BPI. We fitted regression models to estimate the association and the discriminatory accuracy of the BPI with mortality and stroke etiology.
Results
Adjusted for demographic and vascular covariates, the BPI remained independently associated with mortality (odds ratio (OR) 1.68, 95% confidence interval (CI): 1.29-2.18) and cardioembolic stroke etiology (OR 1.38, 95% CI: 1.10-1.74), and improved the discriminatory accuracy to predict mortality (area under the receiver operating characteristic curve (AUC) 0.93, 95% CI: 0.89-0.96) and cardioembolic stroke etiology (AUC 0.70, 95% CI: 0.64-0.77) as compared to the best clinical prediction models alone (AUC 0.89, 95% CI: 0.84-0.94 and AUC 0.66, 95% CI: 0.60-0.73, respectively).
Conclusions
We identified a novel BPI improving risk stratification for mortality after ischemic stroke beyond established demographic and vascular risk factors. Furthermore, the BPI is associated with underlying cardioembolic stroke etiology. These results need external validation.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Bicvic, Antonela |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2396-9873 |
Publisher: |
Sage |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
02 Jun 2022 13:48 |
Last Modified: |
05 Dec 2022 16:20 |
Publisher DOI: |
10.1177/23969873221090798 |
PubMed ID: |
35647313 |
Uncontrolled Keywords: |
Stroke biomarker cardioembolic ischemic mortality prognosis |
BORIS DOI: |
10.48350/170398 |
URI: |
https://boris.unibe.ch/id/eprint/170398 |